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The accumulation of 1-10 µm phospholipid-shelled microbubbles was demonstrated by creating an “ultrasonic
tap” using acoustic travelling waves. Microbubbles were flowed through a 200 µm cellulose tube at rates
ranging between 14-50 ml/hr, in order to approximate the velocities and wall shear rates found throughout
the human circulatory system. The generated acoustic radiation force directly opposing the flow direction
was sufficient to hold microbubbles in a fluid flow up to 28 cm/s. Clusters of microbubbles subject to wall
shear rates of up to 9000 s−1 were retained near a pressure null for several seconds.
Due to renal clearance and enzymatic degradation,
thrombolytic drugs have an insufficient half-life and high
doses have to be administered to obtain satisfying thera-
peutic effects in the treatment of vascular diseases.1 This
leads to higher risks of hemorrhagic complications such
as systemic bleeding. Encapsulation within liposomes or
microbubbles (MB) lowers the protein immunogenecity
and antigenicity, thus considerably extending the agent
half-life. The drug can then be released at the target
site upon insonication. Following intravenous injection,
particle concentration drops significantly due to dilution
throughout the blood volume.2 Research is on-going to
lower the systemic drug dose by improving the specificity
of the delivery method toward the thrombus.1 Attaching
monoclonal antibodies such as antifibrin or antiplatelet
onto the surface of MB slightly improves the efficacy
of sonothrombolysis by increasing their concentration
in the vicinity of the blood clot surface.3 Targeting
the thrombus in this way can also have beneficial
effect on the safety of the delivery method by lowering
the pressure threshold required to induce cavitation.
Laing et al. reported that the targeting of liposomes
to the disintegrating clot surface resulted in particles
being displaced.5 It has been shown that maximising
the amount of cavitation events near the clot surface
can significantly reduce the required systemic drug dose
by facilitating its penetration into the thrombus.6 Since
stable cavitation can play an important role,7 retaining
the cavitation nuclei in the vicinity of the clot surface
can further enhance the safety of the thrombolytic drug
delivery. Non-invasively retaining MB onto the clot
surface using low-intensity ultrasound traveling waves
could benefit existing delivery techniques as it would
apply to MB used as cavitation nuclei and drug-carriers.
The rheological behaviour of MB is similar to that of
red blood cells which means they will generally flow
along the centreline of microvessels.8 Yet, for molecular
recognition to occur, the microbubbles should be within
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10-20 µm of the blood vessel lining or endothelium.9
Acoustic radiation force can be used to “push” flowing
MB towards the vessel walls to facilitate binding.10
Rychak et al.11 demonstrated a 44 fold increase in the
number of bound MB through the use of radiation force,
for a wall shear rate of 355 s−1 (centre frequency 2 MHz
and peak negative pressure 122 kPa). However, there
was still a drop of 75 % in the amount of bound MB,
when the wall shear rate was increased to 1244 s−1.
Takalkar et al.12 demonstrated that, once bound, MB
can withstand wall shear rates of up to 16000 s−1 but
the amount of MB retained was already down by 50%
at 3400 s−1.
In this letter we report on the creation of an acoustic
radiation force tap to non-invasively trap and hold
flowing MB at a single location. A null in the pressure
field was created across a tube cross-section by emitting
two ultrasound beams of opposite phase. The input
beam duty factor was set to be lower than that of the
output beam so that MB could enter the low-pressure
region. Once trapped, MB were subject to a trapping
force directly opposing the fluid flow. For wall shear
rates of up to 9000 s−1, MB aggregates were held within
a low-pressure region (peak negative pressure < 350 kPa)
for several seconds. An OEM diagnostic ultrasound
probe was used to generate a pressure field with a centre
frequency of 7 MHz, which is within the 1-10 MHz
frequency range for ultrasound medical imaging.
Fig. 1 illustrates the use of the ultrasonic tap to accu-
mulate and retain a MB population at the target site.
The flowing MB formed aggregates as they first entered
the ultrasound field. A translation towards the opposite
tube wall then occurred near the peak of the input
beam where the primary radiation force (PRF) is more
significant. The Bjerknes principle predicts that MB
excited above resonance are attracted to the pressure
minima of an ultrasound field.13 In the set-up shown in
Fig. 1 a sufficient trapping force (TF) was generated to
accumulate MB against the flow, within the low-pressure
region. The excitation frequency was always set to
7 MHz, hence not all MB were affected by the trapping
force.
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FIG. 1. (Top) A micrograph of the cellulose tube showing
MB aggregation retained near the pressure null. (Middle)
Schematic describing how the primary radiation force (PRF)
causes MB aggregation and translation towards the opposite
tube wall. The engendered trapping force (TF) directly op-
poses the flow direction thus trapping MB clusters. (Bottom)
Simulated (dotted line) and measured (continuous line) lat-
eral peak negative pressure (PNP) at the focal depth. The
face of the linear array is parallel to the tube axis and the
pressure null is aligned to its centre.
The generation of a pressure null through the interfer-
ence of two acoustic waves of opposite phase was first
verified experimentally. The 96-channel Ultrasound
Array Research Platform14 was used to drive a one-
dimensional diagnostic ultrasound probe (L3-8/40EP,
Prosonic, Korea). A 96-element aperture was focused at
a depth of 30 mm. Two 48-element subapertures were
configured to emit identical ultrasound pulses, with a
phase shift of pi. Fig. 1 shows a plot of the measured
pressure field using a 200 µm needle hydrophone (Preci-
sion Acoustics Ltd., Dorchester, UK) mounted on a 3-D
computer controlled translation system. The ultrasound
probe and hydrophone were submerged within a tank
of de-ionized and de-gassed water at 20±1◦C. With the
driving voltage set to its minimum and for a centre
frequency of 7 MHz, the peak negative pressure (PNP)
was measured to be 350 kPa for a lateral position of
+200 µm and -200 µm. The width and slope gradient of
the low-pressure region approximated the data simulated
using the Field II package.15,16
Lipids were prepared by dissolving 1,2-
Dipalmitoyl-snglycero-3-phosphocholine (DPPC),
1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-
N-[maleimide(polyethylene glycol)-2000] (DSPE-
PEG2000), and 1,2-Dipalmitoyl-sn-glycero-3-phosphate
(DPPA) from Avanti Polar Lipids (Alabaster, AL) in
chloroform and drying them in a glass vial by a vacuum
desiccator. Microbubbles were then obtained by resus-
pending the dried lipids in Dulbecco Phosphate-Buffered
Saline (DPBS) with 1% glycerin by volume in a 1 mL
vial. The solution was then saturated with C3F8 before
being shaken for 45 seconds using a mechanical shaker.
MB were then diluted in a cylindrical chamber that was
immersed in de-gassed and de-ionized water at 20◦C.
The chamber was placed onto a mechanical stirrer to
continuously mix its content during the experiment. A
1 mm hydrophone was located 10 mm from the chamber
and at 90◦ in relation to a 5 MHz V310 transducer
(Olympus-NDT Inc., Waltham, MA, USA) to acquire
the scatter frequency spectrum from 3 to 8 MHz with
0.1 MHz steps. The average resonant frequency was
measured to be 3.8 MHz. Micrographs of diluted MB
were obtained using light microscopy and then analyzed
using ImageJ (National Institute of Health, USA). The
MB size distribution ranged from 1 to 10 µm with a
mean diameter of 2 µm.
The MB were diluted to 40×106 MB/ml in de-gassed and
de-ionised water then flowed through a 200 µm cellulose
tube that was optically and acoustically transparent.
The fluid flow rate was regulated with a programmable
syringe pump (Aladdin-1000, World Precision Instru-
ments, Sarasota, FL, USA), and an inverted microscope
(Eclipse Ti-U, Nikon, Melville, NY, USA) was used to
optically image the tube. The ultrasound probe was
aligned orthogonal to the tube and at a 45◦ angle in
relation to the bottom of the tank.
When the “ultrasonic tap” was first applied, MB aggre-
gated before the input beam and were unable to enter
the low-pressure region. To remedy this, the ultrasonic
tap was made to be asymmetrical by setting the input
subaperture duty factor δi to be lower than that of
the output subaperture, δo. To estimate what would
be the best ratio α = δi/δo, a concentration (CB) of
1×109 MB/ml was flowed at a rate Q = 10 ml/hr. The
output subaperture duty factor was set to 57 % with
a pulse repetition frequency of 10 kHz and a PNP of
350 kPa. The experiment was repeated for α = 0.25,
0.5, 0.75 and 1. The most efficient accumulation was
observed for a ratio α = 0.5.
For the same ultrasound parameters, the performance
of the ultrasonic tap was then evaluated at different
flow rates with CB = 40×10
6 MB/ml. Image processing
was performed in Matlab (Mathworks Inc., Natick, MA,
USA) on the recorded videos to track the diameter and
position of the largest cluster. The cluster accumulation
duration tacc and the maximum diameter dmax it
reached are listed in table I for each value of Q. The
cluster resting position before it exit the trap was always
between 70 and 110 µm from the pressure null. For
a flow rate of 40 ml/hr a 9.5 µm cluster was retained
70 µm away from the pressure null for 1.4 s.
The syringe driver was then set to its maximum
flow rate of 50 ml/hr and the output duty factor was
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FIG. 2. In the series of micrographs (a)-(f) the flow rate and
concentration were 50 ml/hr and 40×106 MB/ml respectively.
The vertical dotted lines at the centre of each micrograph rep-
resent the pressure null. (g) is a plot of the largest trapped
cluster diameter (dotted line) and position (continuous line).
The centre frequency was 7 MHz, the pulse repetition fre-
quency 10 kHz, the PNP of 500 kPa, δs = 71% and α = 0.5.
increased to 71 %. The ratio between input and output
duty factor was kept at 0.5. For a PNP of 350 kPa, a
12 µm cluster was retained 95 µm beyond the pressure
null for 1.6 s. The cluster diameter then became too
great for the trapping force to retain it. To intensify
the trapping force, the PNP was raised to 500 kPa.
Fig. 2(a)-(f) is a series of micrographs acquired at
different times during the experiment. The tracking of
the cluster diameter and position are plotted in Fig. 2(g).
Before the ultrasound source was activated (Fig. 2(a))
TABLE I. Maximum cluster diameter dmax and accumula-
tion duration tacc for an increasing flow rate Q. The ultra-
sound parameters were constant with a centre frequency of
7 MHz, a pulse repetition frequency of 10 kHz, a PNP of
350 kPa, δs = 57% and α = 0.5. The MB concentration was
40×106 MB/ml.
Q (ml/hr) 14 16 20 30 40
dmax (µm) 32 22 19 11.9 9.5
tacc (s) 13 5.3 4.5 2.7 1.4
only imperfections were visible between the tube walls.
Although MB were flowing past the region imaged,
they were not visible due to the high flow rate. It took
3 s for a first cluster to enter the low-pressure region
(Fig. 2(g)). In Fig. 2(b) it had reached a diameter of
11.4 µm and continued to accumulate MB for a further
5 s. As it then stopped accumulating MB, its diameter
and position remained around 19 µm and 90 µm for 7 s.
In Fig. 2(d) the cluster size increased beyond 20 µm and,
as the trapping force wasn’t sufficient, it started to shift
away. It was replaced by a smaller 7 µm cluster that
remained held (Fig. 2(e)) until the end of the ultrasound
exposure (Fig. 2(f)).
In Newtonian flow the wall shear rate is γw = 32Q/piD
3
and the corresponding mean velocity is vz = Dγw/8.
The tube internal diameter D was observed to expand
to 250 µm when filled with water. Thus, a flow rate
of 50 ml/hr was expected to induce mean velocities
nearing 28 cm/s and wall shear rates of up to 9000 s−1.
Applying radiation force orthogonal to the flow in large
arteries to stop flowing MB remains a challenge as
mean velocities can reach several cm/s. Patil et al.17
reported that, even when excited near resonance, a
mechanical index of 0.15 was required to halt MB for a
wall shear rate of 52 s−1. Moreover, flowing MB clusters
can impede accumulation by engulfing already bound
targeted MB.9 Through the generation of a trapping
force directly opposing the flow, the ultrasonic tap was
able to halt MB subject to wall shear rates of up to
9000 s−1. Yet the mechanical index of the pressure
field at the focal depth was 0.13. The diameter of the
tube used in the experiments was similar to that of
capillaries. However, for the same mean velocity, the MB
accumulation is expected to be more significant in larger
vessels such as arteries due to the lower wall shear rates.
Fig. 2 demonstrates that, instead of attracting trapped
MB as they flow past, clusters would accumulate at the
target site.
Maxwell et al.18 recently reported on the ability to use
standard imagine techniques such as power doppler and
B-mode imaging to guide and monitor clot fragmentation
in porcine models. The same principle could be applied
with the ultrasonic tap to align MB clusters to the clot
surface. Shifting the input and output subapertures
across the array elements would laterally translate the
pressure null along the thrombus without having to
4move the transducer itself. There is a clear advantage
in using a single ultrasound transducer not only to
image the target region but also induce stable cavitation
to enhance clot permeation and inertial cavitation
to released encapsulated drugs.1 In this preliminary
study it was demonstrated that a standard linear array
could be used to induce a low-pressure region capable
of retaining MB subject to wall shear rates of up to
9000 s−1.
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